Advertisement
Screener

Onconetix, Inc. (ONCO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Onconetix, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Onconetix, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $9.68M went out.
  • Fiscal year ended 2025-12-31: from financing, $14.45M came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.57M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$9.68M$6.39M$8.06M*$4.57M
2024-12-31-$10.50M-$28.47K$685.28K$6.06M*-$3.91M
2023-12-31-$13.58M-$8.65M$459.00$1.03M*-$21.20M
2022-12-31-$8.68M-$32.66K$1.66K$32.53M*$23.82M
2021-12-31-$2.04M-$1.92K-$2.38M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$1.92M*$4.17M*
2026-03-31-$2.12M$631.79K*-$1.50M
2025-12-31-$3.09M*$21.00*$6.55M*
2025-09-30-$3.18M*-$21.00*$4.29M*
2025-06-30-$1.41M*$1.37M*-$620.46K*
2025-03-31-$2.00M$5.03M-$2.16M*$930.69K
2024-12-31-$917.65K*-$3.87K*$0.00*$1.30M*
2024-09-30-$1.15M*-$2.31K*$0.00*$578.64K*
2024-06-30-$3.20M*-$17.71K*
2024-03-31-$5.23M-$4.58K$5.21M*-$90.47K
2023-12-31-$4.31M*$1.22M*$0.00*
2023-09-30-$3.04M*$173.01K*$0.00*$1.30M*
2023-06-30-$1.82M*-$10.00M*-$25.53K*
2023-03-31-$4.41M-$36.27K-$33.45K-$4.50M
2022-12-31-$2.80M*-$1.18K*$0.00*-$582.84K*
2022-09-30-$1.81M*-$14.31K*$9.15M*
2022-06-30-$3.17M*-$11.98K*$6.82M*
2022-03-31-$886.09K-$5.20K$17.57M*$16.68M
2021-12-31-$674.40K*
2021-09-30-$730.48K*
2021-06-30-$382.81K*
2021-03-31-$256.55K-$256.55K

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90